'Holy Grail' of HIV Vaccine Trials Launched in South Africa

Professor Linda-Gail Bekker from the University of Cape Town hopes the HVTN 702 vaccine will lead to a breakthrough in combating the virus after the first results of the current trials are published by the end of 2020.



Video

Photo: UNAIDS

World Aids Day 2016.

InFocus